[
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community .\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often preven",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "REQUIRES organism part SHALL developmental stage CS PTM URL THE HCD MHC BMC individual LC ancestry category MINOR PRIDE:0000832 NCIT:C25714 SDRF INFORMATION SILAC CL DJ MAJOR CT AC NOT DDA ... age WARRANTIES PEPTIDESEQ MAGE PRIDE:0000831 ALL depletion BUT RAW URI fraction identifier collision energy PURPOSE ISA SP ANY PRM SAMN RIGHTS PRIDE:0000833 biosample accession number VCF FDR SAMEA RECOMMEND UBERON DTT NCI FITNESS IS ROW cell type DIA HF MUST WARRANTY SHOULD file your NCE RFC ZFA INITIATIVE NT AS MONDO PATCH HEREIN MC pooled sample FOR characteristics XL PATO MT IAA source name TA HUPO III TMT CID QY INCLUDING disease data file OF STANDARDS ENVO PP reduction reagent IDF cleavage agent details TO README ID CV CELL instrument sample EXPRESS mass MS BE EM fractionation method BTO COULD PRIDE:0000834 WILL EW TAB PS PMID NCIT:C25683 JA LIMITED CPTAC DISCLAIMS PARTICULAR OR alkylation reagent HTML IMPORTANT SRM SH PSI organism USE LI MOD label sex MERCHANTABILITY CF II INFRINGE REQUIRED SN SWATH MS:1001251 PROTEOMICS BRENDA HANCESTRO RECOMMENDED PRIDE:0000659 CN EBI EFO IMPLIED PMCID spiked compound XML dissociation method PO technical replicate MIAME proteomics data acquisition method THAT NCBI NOTE MAY VK NCIT PRIDE biological replicate OPTIONAL COLUMN CLO TIP exclamation"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community .\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often preven",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "REQUIRES organism part SHALL CS PTM URL THE HCD MHC BMC individual LC MINOR PRIDE:0000832 NCIT:C25714 SDRF INFORMATION SILAC CL DJ MAJOR CT AC NOT DDA ... age WARRANTIES PEPTIDESEQ MAGE PRIDE:0000831 ALL depletion BUT RAW URI fraction identifier collision energy PURPOSE ISA SP ANY PRM SAMN RIGHTS PRIDE:0000833 biosample accession number VCF FDR SAMEA RECOMMEND UBERON DTT NCI FITNESS IS ROW cell type DIA MUST HF WARRANTY SHOULD NCE RFC ZFA INITIATIVE NT AS MONDO PATCH HEREIN MC pooled sample FOR XL PATO MT IAA TA HUPO III TMT CID QY INCLUDING disease data file OF STANDARDS ENVO PP reduction reagent IDF cleavage agent details TO README CV CELL EXPRESS mass MS BE EM fractionation method BTO COULD PRIDE:0000834 WILL EW TAB PS PMID NCIT:C25683 JA LIMITED CPTAC DISCLAIMS PARTICULAR OR alkylation reagent HTML SRM SH PSI organism USE LI MOD label MERCHANTABILITY CF II INFRINGE REQUIRED SN SWATH MS:1001251 PROTEOMICS BRENDA HANCESTRO RECOMMENDED PRIDE:0000659 CN EBI EFO IMPLIED PMCID spiked compound dissociation method PO technical replicate MIAME proteomics data acquisition method THAT NCBI MAY VK NCIT PRIDE biological replicate OPTIONAL COLUMN CLO instrument"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nFor human-specific metadata (disease staging, comorbidities, treatment history), see Human Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nOrganism\n\nColumn: characteristics[organism]\n\nOntology: NCBI Taxonomy (NCBITaxon)\n\nUse the scientific name in lowercase. The validator will map to the correct ontology term.\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens |NCBITaxon:9606 |Human\nmus musculus |NCBITaxon:10090 |Mouse\n\nOrganism Part / Tissue\n\nColumn: characteristics[organism part]\n\nOntology: UBERON for mammals/vertebrates, Plant Ontology (PO) for plants, FlyBase Anatomy (FBbt) for Drosophila.\n\nUse lowercase for all values. For cell line samples, use not applicable or specify the tissue of origin (e.g., cervix for HeLa).\n\nValue |UBERON ID |Description\n\nblood |UBERON:0000178 |Whole blood\nliver |UBERON:0002107 |Liver tissue\n\nAge\n\nColumn: characteristics[age]\n\nFormat: {Number}{Unit} where Unit is: Y (Years), M (Months), W (Weeks), D (Days).\n\nFor age ranges use: {LowerBound}{Unit}-{UpperBound}{Unit} (e.g., 40Y-50Y).\n\nUse not available when age is unknown, not applicable for immortalized cell lines.\n\nAge Description |SDRF Value\n\n40 years old |40Y\n8 weeks old |8W\n\nDevelopmental Stage\n\nColumn: characteristics[developmental stage]\n\nOntology: UBERON, EFO\n\nValue |Description\n\nadult |Sexually mature organism\nembryonic |Pre-birth/pre-hatching\n\nFor model organisms, use specific stages when applicable: embryonic day 14 (mouse E14), 24 hpf (zebrafish 24 hours post fertilization).\n\nBiological Sex\n\nColumn: characteristics[sex]\n\nOntology: PATO\n\nUse lowercase for all values. For cell lines, sex reflects the original donor.\n\nValue |PATO ID |Description\n\nmale |PATO:0000384 |Biological male\nfemale |PATO:0000383 |Biological female\n\nUse not available when sex is unknown, ",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "organism part developmental stage APP DOID PTM UBERON MONDO:0004989 synthetic peptide CL:0000084 CL:0000066 individual cell type ancestry category PATO:0000383 CL:0000624 MUST ID PDX SDRF PATO:0000384 HANCESTRO MONDO CL EFO PATO UBERON:0000178 age enrichment process CL:0000815 PO PATO:0000461 depletion disease NCBI MAY organism UBERON:0002107 biological replicate exclamation xenograft sex"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nFor human-specific metadata (disease staging, comorbidities, treatment history), see Human Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nOrganism\n\nColumn: characteristics[organism]\n\nOntology: NCBI Taxonomy (NCBITaxon)\n\nUse the scientific name in lowercase. The validator will map to the correct ontology term.\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens |NCBITaxon:9606 |Human\nmus musculus |NCBITaxon:10090 |Mouse\n\nOrganism Part / Tissue\n\nColumn: characteristics[organism part]\n\nOntology: UBERON for mammals/vertebrates, Plant Ontology (PO) for plants, FlyBase Anatomy (FBbt) for Drosophila.\n\nUse lowercase for all values. For cell line samples, use not applicable or specify the tissue of origin (e.g., cervix for HeLa).\n\nValue |UBERON ID |Description\n\nblood |UBERON:0000178 |Whole blood\nliver |UBERON:0002107 |Liver tissue\n\nAge\n\nColumn: characteristics[age]\n\nFormat: {Number}{Unit} where Unit is: Y (Years), M (Months), W (Weeks), D (Days).\n\nFor age ranges use: {LowerBound}{Unit}-{UpperBound}{Unit} (e.g., 40Y-50Y).\n\nUse not available when age is unknown, not applicable for immortalized cell lines.\n\nAge Description |SDRF Value\n\n40 years old |40Y\n8 weeks old |8W\n\nDevelopmental Stage\n\nColumn: characteristics[developmental stage]\n\nOntology: UBERON, EFO\n\nValue |Description\n\nadult |Sexually mature organism\nembryonic |Pre-birth/pre-hatching\n\nFor model organisms, use specific stages when applicable: embryonic day 14 (mouse E14), 24 hpf (zebrafish 24 hours post fertilization).\n\nBiological Sex\n\nColumn: characteristics[sex]\n\nOntology: PATO\n\nUse lowercase for all values. For cell lines, sex reflects the original donor.\n\nValue |PATO ID |Description\n\nmale |PATO:0000384 |Biological male\nfemale |PATO:0000383 |Biological female\n\nUse not available when sex is unknown, ",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "organism part developmental stage APP DOID PTM UBERON MONDO:0004989 synthetic peptide CL:0000084 CL:0000066 individual cell type ancestry category PATO:0000383 CL:0000624 MUST ID PDX SDRF PATO:0000384 HANCESTRO MONDO CL EFO PATO UBERON:0000178 age enrichment process CL:0000815 PO PATO:0000461 depletion disease NCBI MAY organism UBERON:0002107 biological replicate xenograft sex"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to clinical studies and healthy human samples.\n\nFor general sample metadata (organism, age, sex, basic disease), see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nDisease Stage\n\nColumn: characteristics[disease stage]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nstage I |NCIT:C27966 |Early localized disease\nstage IV |NCIT:C27971 |Distant metastasis\n\nUse not available when stage is unknown, not applicable for non-cancer samples.\n\nTNM Staging\n\nColumn: characteristics[TNM staging]\n\nOntology: NCI Thesaurus (NCIT)\n\nFormat: T{0-4}N{0-3}M{0-1} where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix p indicates pathological staging.\n\nValue |Description\n\nT1N0M0 |Small tumor, no nodes, no metastasis\npT2pN1M0 |Pathological staging after surgery\n\nTumor Grade\n\nColumn: characteristics[tumor grade]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\ngrade 1 |NCIT:C28076 |Well differentiated\ngrade 3 |NCIT:C28078 |Poorly differentiated\n\nCancer-Specific Classifications\n\nBreast cancer subtype (characteristics[breast cancer subtype]):\n\nValue |NCIT ID |Description\n\nluminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67\ntriple-negative |NCIT:C71732 |ER-/PR-/HER2-\n\nOther classifications: characteristics[Dukes stage] for colorectal cancer, characteristics[Ann Arbor stage] for lymphoma.\n\nPre-existing Condition\n\nColumn: characteristics[pre-existing condition]\n\nOntology: MONDO Disease Ontology\n\nFor multiple conditions, use multiple columns (preferred) or semicolon-separated values.\n\nCondition |SDRF Value |MONDO ID\n\nHigh blood pressure |hypertension |MONDO:0005044\nDiabetes |type 2 diabetes mellitus |MONDO:0005148\n\nTreatment\n\nColumn: characteristics[treatment]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nchemotherapy |NCIT:C15632 |Chemical drug treatm",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "NCIT:C4870 organism part menopausal status NCIT:C27971 smoking status HANCESTRO:0009 AJCC individual NCI PR TNM staging MONDO:0005148 NCIT:C65108 disease stage treatment TNM ID weight ancestry category MONDO:0005044 treatment status SDRF NCIT:C28076 HANCESTRO treatment response IV NCIT:C71732 pre-existing condition MONDO GDPR NCIT:C53554 Ann Arbor stage CHEBI:27899 NCIT:C65107 NCIT:C15262 NCIT:C65106 NCIT:C28078 NCIT:C27966 body mass index tumor grade sampling time point breast cancer subtype IMPORTANT compound NCIT CHEBI:28748 NCIT:C18206 HANCESTRO:0005 HIPAA dose ER exclamation Dukes stage NCIT:C15632"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to clinical studies and healthy human samples.\n\nFor general sample metadata (organism, age, sex, basic disease), see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nDisease Stage\n\nColumn: characteristics[disease stage]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nstage I |NCIT:C27966 |Early localized disease\nstage IV |NCIT:C27971 |Distant metastasis\n\nUse not available when stage is unknown, not applicable for non-cancer samples.\n\nTNM Staging\n\nColumn: characteristics[TNM staging]\n\nOntology: NCI Thesaurus (NCIT)\n\nFormat: T{0-4}N{0-3}M{0-1} where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix p indicates pathological staging.\n\nValue |Description\n\nT1N0M0 |Small tumor, no nodes, no metastasis\npT2pN1M0 |Pathological staging after surgery\n\nTumor Grade\n\nColumn: characteristics[tumor grade]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\ngrade 1 |NCIT:C28076 |Well differentiated\ngrade 3 |NCIT:C28078 |Poorly differentiated\n\nCancer-Specific Classifications\n\nBreast cancer subtype (characteristics[breast cancer subtype]):\n\nValue |NCIT ID |Description\n\nluminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67\ntriple-negative |NCIT:C71732 |ER-/PR-/HER2-\n\nOther classifications: characteristics[Dukes stage] for colorectal cancer, characteristics[Ann Arbor stage] for lymphoma.\n\nPre-existing Condition\n\nColumn: characteristics[pre-existing condition]\n\nOntology: MONDO Disease Ontology\n\nFor multiple conditions, use multiple columns (preferred) or semicolon-separated values.\n\nCondition |SDRF Value |MONDO ID\n\nHigh blood pressure |hypertension |MONDO:0005044\nDiabetes |type 2 diabetes mellitus |MONDO:0005148\n\nTreatment\n\nColumn: characteristics[treatment]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nchemotherapy |NCIT:C15632 |Chemical drug treatm",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "NCIT:C4870 organism part menopausal status NCIT:C27971 smoking status HANCESTRO:0009 AJCC individual NCI PR TNM staging MONDO:0005148 NCIT:C65108 disease stage treatment TNM ID weight ancestry category MONDO:0005044 treatment status SDRF NCIT:C28076 HANCESTRO treatment response IV NCIT:C71732 pre-existing condition MONDO GDPR NCIT:C53554 Ann Arbor stage CHEBI:27899 NCIT:C65107 NCIT:C15262 NCIT:C65106 NCIT:C28078 NCIT:C27966 body mass index tumor grade sampling time point breast cancer subtype compound NCIT CHEBI:28748 NCIT:C18206 HANCESTRO:0005 HIPAA dose ER Dukes stage NCIT:C15632"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format, describing the relationship between samples and MS run files, instrument configurations, and analysis parameters.\n\nData file properties use the comment prefix to differentiate from sample properties (characteristics).\n\nFor sample metadata guidelines, see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nAssay Name\n\nColumn: assay name\n\nUnique identifier for an MS run (data file). Each distinct MS run MUST have exactly one globally unique assay name.\n\nUniqueness rules:\n\n- source name + assay name + comment[label] MUST be unique (error if not)\n- source name + assay name SHOULD be unique (warning if not)\n\nFormat |Example\n\nsamplerun |sample1run1\nsamplefractionreplicate |sample1F1R1\n\nFor multiplexed experiments (TMT, iTRAQ, SILAC), multiple rows may reference the same assay name with different labels.\n\nTechnology Type\n\nColumn: technology type\n\nOntology: PRIDE Ontology (PRIDE:0000663)\n\nREQUIRED for all MS-based SDRF files. Should be placed immediately after assay name.\n\nValue |Use Case\n\nproteomic profiling by mass spectrometry |DDA, DIA, PRM, SRM experiments\nprotein profiling by proximity extension assay |Olink panels\n\nData Acquisition Method\n\nColumn: comment[proteomics data acquisition method]\n\nOntology: PRIDE Ontology\n\nREQUIRED for all MS-based SDRF files.\n\nValue |Description\n\ndata-dependent acquisition |DDA - precursors selected based on intensity\ndata-independent acquisition |DIA - systematic fragmentation of all precursors\n\nLabel\n\nColumn: comment[label]\n\nOntology: PRIDE Ontology - Label\n\nDescribes the isotopic label applied to each sample.\n\nLabel-free: Use label free sample.\n\nTMT labels: TMT126, TMT127N, TMT127C, TMT128N, TMT128C, TMT129N, TMT129C, TMT130N, TMT130C, TMT131N, TMT131C, TMT132N, TMT132C, TMT133N, TMT133C, TMT134N, TMT134C, TMT135N\n\niTRAQ labels: iTRAQ113, iTRAQ114, iTRAQ115, iTRAQ116, iTRAQ117, iTRAQ118, iTRAQ119",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "PP fragment mass tolerance URL proteomexchange accession number file uri REQUIRED UNIMOD cleavage agent details MGF DIA HF MUST ID MS:1001251 MS2 analyzer type SHOULD precursor mass tolerance MS SDRF RECOMMENDED NT PRIDE:0000663 SILAC MS1 scan range UNIMOD:4 AC DDA MT fraction scan window upper limit TA UNIMOD:35 technical replicate TMT proteomics data acquisition method scan window lower limit modification parameters data file RAW URI SRM fraction identifier PRIDE PSI MOD instrument exclamation MS:1001309 label PRM"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format, describing the relationship between samples and MS run files, instrument configurations, and analysis parameters.\n\nData file properties use the comment prefix to differentiate from sample properties (characteristics).\n\nFor sample metadata guidelines, see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nAssay Name\n\nColumn: assay name\n\nUnique identifier for an MS run (data file). Each distinct MS run MUST have exactly one globally unique assay name.\n\nUniqueness rules:\n\n- source name + assay name + comment[label] MUST be unique (error if not)\n- source name + assay name SHOULD be unique (warning if not)\n\nFormat |Example\n\nsamplerun |sample1run1\nsamplefractionreplicate |sample1F1R1\n\nFor multiplexed experiments (TMT, iTRAQ, SILAC), multiple rows may reference the same assay name with different labels.\n\nTechnology Type\n\nColumn: technology type\n\nOntology: PRIDE Ontology (PRIDE:0000663)\n\nREQUIRED for all MS-based SDRF files. Should be placed immediately after assay name.\n\nValue |Use Case\n\nproteomic profiling by mass spectrometry |DDA, DIA, PRM, SRM experiments\nprotein profiling by proximity extension assay |Olink panels\n\nData Acquisition Method\n\nColumn: comment[proteomics data acquisition method]\n\nOntology: PRIDE Ontology\n\nREQUIRED for all MS-based SDRF files.\n\nValue |Description\n\ndata-dependent acquisition |DDA - precursors selected based on intensity\ndata-independent acquisition |DIA - systematic fragmentation of all precursors\n\nLabel\n\nColumn: comment[label]\n\nOntology: PRIDE Ontology - Label\n\nDescribes the isotopic label applied to each sample.\n\nLabel-free: Use label free sample.\n\nTMT labels: TMT126, TMT127N, TMT127C, TMT128N, TMT128C, TMT129N, TMT129C, TMT130N, TMT130C, TMT131N, TMT131C, TMT132N, TMT132C, TMT133N, TMT133C, TMT134N, TMT134C, TMT135N\n\niTRAQ labels: iTRAQ113, iTRAQ114, iTRAQ115, iTRAQ116, iTRAQ117, iTRAQ118, iTRAQ119",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "PP fragment mass tolerance URL proteomexchange accession number file uri REQUIRED UNIMOD cleavage agent details MGF DIA HF MUST ID MS:1001251 MS2 analyzer type SHOULD precursor mass tolerance MS SDRF RECOMMENDED NT PRIDE:0000663 SILAC MS1 scan range UNIMOD:4 AC DDA MT scan window upper limit TA UNIMOD:35 technical replicate TMT proteomics data acquisition method scan window lower limit modification parameters data file RAW URI SRM fraction identifier PRIDE PSI MOD instrument MS:1001309 label PRM"
  }
]